Literature DB >> 14656613

Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromes.

John H Alexander1, Robert A Harrington, Manju Bhapkar, Kenneth W Mahaffey, A Michael Lincoff, E Magnus Ohman, Peter Klootwijk, Olle Pahlm, Bo Henden, Jaap W Deckers, Maarten L Simoons, Robert M Califf, Galen S Wagner.   

Abstract

PURPOSE: To investigate the prognostic importance of new small Q waves following an acute coronary syndrome.
METHODS: We assessed 6-month mortality in 10501 patients with non-ST-elevation acute coronary syndromes who had survived 30 days and had both admission and 30-day electrocardiograms. Patients were stratified by whether they had no new Q waves (n = 9447), new 30- to 40-ms Q waves (n = 733), or new > or =40-ms Q waves (n = 321).
RESULTS: Mortality was higher in patients with 30- to 40-ms Q waves than in those with no new Q waves (3.4% [25/733] vs. 2.4% [227/9447], P = 0.005), and even higher in those with > or =40-ms Q waves (5.3% [17/321], P = 0.002). After adjustment for baseline risk predictors, mortality remained higher in patients with new 30- to 40-ms Q waves (odds ratio [OR] = 1.30; 95% confidence interval [CI]: 0.85 to 1.98; P = 0.23) and those with new > or =40-ms Q waves (OR = 1.87; 95% CI: 1.13 to 3.09; P = 0.01).
CONCLUSION: Patients with new small Q waves following a non-ST-elevation acute coronary syndrome are at increased risk of adverse outcomes. These small Q waves should be considered diagnostic of myocardial infarction. Further research should investigate whether even smaller QRS changes are prognostically important.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656613     DOI: 10.1016/j.amjmed.2003.08.007

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  1 in total

1.  Diagnostic significance of a small Q wave in precordial leads V(2) or V(3).

Authors:  Tetsuya Katsuno; Kenzo Hirao; Shigeki Kimura; Masatoshi Komura; Go Haraguchi; Hiroshi Inagaki; Hitoshi Hachiya; Mitsuaki Isobe
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-04       Impact factor: 1.468

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.